{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:10:08Z","timestamp":1792001408178,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.radonc.2026.111404","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:24:41Z","timestamp":1769531081000},"page":"111404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A robustness-inclusive comparison of proton- versus photon-based whole-pelvic radiotherapy for prostate cancer within a randomised clinical trial"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3447-5667","authenticated-orcid":false,"given":"Sofie","family":"Tilb\u00e6k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6516-6477","authenticated-orcid":false,"given":"Stine Elleberg","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-3350","authenticated-orcid":false,"given":"Liliana","family":"Stolarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6424-4687","authenticated-orcid":false,"given":"Kasper Lind","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen Bjerre","family":"Hokland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan BlakNyrup","family":"Biancardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Legaard","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus","family":"Havelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terje","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8889-2797","authenticated-orcid":false,"given":"Bjarke","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Vesterg\u00e5rd","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Schwartz","family":"Vittrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorthe","family":"Yakymenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmi","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludvig Paul","family":"Muren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111404_b0005","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1200\/JCO.20.03282","article-title":"Prostate-only versus whole-pelvic radiation therapy in high-risk and very high-risk prostate cancer (POP-RT): Outcomes from phase III randomized controlled trial","volume":"39","author":"Murthy","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0010","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.ijrobp.2017.07.041","article-title":"Phase 1\/2 dose-escalation study of the use of intensity modulated radiation therapy to treat the prostate and pelvic nodes in patients with prostate cancer","volume":"99","author":"Reis Ferreira","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.euf.2022.09.005","article-title":"Evaluating the impact of prostate only versus pelvic radiotherapy for pathological node-positive prostate cancer: first results from the multicenter phase 3 PROPER trial","volume":"9","author":"Fonteyne","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.radonc.2026.111404_b0020","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ijrobp.2007.11.060","article-title":"Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences","volume":"71","author":"Muren","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0025","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.ijrobp.2008.04.011","article-title":"Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer","volume":"71","author":"Hysing","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF03178602","article-title":"A comparison of proton therapy and IMRT treatment plans for prostate radiotherapy","volume":"31","author":"Dowdell","year":"2008","journal-title":"Australas Phys Eng Sci Med"},{"key":"10.1016\/j.radonc.2026.111404_b0035","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.ijrobp.2010.10.005","article-title":"Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis","volume":"80","author":"Widesott","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/0284186X.2023.2224925","article-title":"In silico comparison of whole pelvis intensity-modulated photon versus proton therapy for the postoperative management of prostate cancer","volume":"62","author":"Gogineni","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0045","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1118\/1.3604152","article-title":"Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images","volume":"38","author":"Wang","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/0284186X.2012.752860","article-title":"Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets","volume":"52","author":"Th\u00f6rnqvist","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0055","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/0284186X.2017.1317107","article-title":"Evaluating the influence of organ motion during photon vs. proton therapy for locally advanced prostate cancer using biological models","volume":"56","author":"Busch","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0060","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3389\/fonc.2019.00940","article-title":"Dosimetric impact of interfractional variations in prostate cancer radiotherapy-implications for imaging frequency and treatment adaptation","volume":"9","author":"Bostel","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/0284186X.2021.1892181","article-title":"Anatomically robust proton therapy using multiple planning computed tomography scans for locally advanced prostate cancer","volume":"60","author":"Busch","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0070","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3109\/0284186X.2011.590522","article-title":"Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques","volume":"50","author":"Th\u00f6rnqvist","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0075","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1080\/0284186X.2023.2261621","article-title":"Plan robustness evaluation strategies in whole-pelvic proton therapy for high-risk prostate cancer patients within a randomised clinical trial","volume":"62","author":"Tilb\u00e6k","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0080","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/0284186X.2017.1317108","article-title":"Beam angle evaluation to improve inter-fraction motion robustness in pelvic lymph node irradiation with proton therapy","volume":"56","author":"Gravgaard Andersen","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phro.2018.11.009","article-title":"On-line dose-guidance to account for inter-fractional motion during proton therapy","volume":"9","author":"Busch","year":"2018","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0090","doi-asserted-by":"crossref","unstructured":"Vestergaard CD, Muren LP, Elstr\u00f8m UV, et al. Daily proton dose re-calculation on deep-learning corrected cone-beam computed tomography scans.Radiother Oncol. Published online May 22, 2025. doi:10.1016\/j.radonc.2025.110953.","DOI":"10.1016\/j.radonc.2025.110953"},{"key":"10.1016\/j.radonc.2026.111404_b0095","unstructured":"Lymph Node Radiation Therapy with Integrated Boost to Prostate for High-risk Prostate Cancer a Randomized Phase 3 Trial Comparing Photons Vs. Protons, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05350475; 2022 [accessed June 23, 2025]."},{"key":"10.1016\/j.radonc.2026.111404_b0100","article-title":"Proton therapy planning and image-guidance strategies within a randomized controlled trial for high-risk prostate cancer","volume":"41","author":"Tilb\u00e6k","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1118\/1.597396","article-title":"ICRU report 50 \u2013 prescribing, recording, and reporting photon beam therapy","volume":"21","author":"Jones","year":"1994","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using Lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"10.1016\/j.radonc.2026.111404_b0115","unstructured":"R Documentation. Fit Linear Mixed-Effects Models, https:\/\/search.r-project.org\/CRAN\/refmans\/lme4\/html\/lmer.html; 2025 [accessed 23 June 2025]."},{"key":"10.1016\/j.radonc.2026.111404_b0120","doi-asserted-by":"crossref","DOI":"10.1118\/1.4892601","article-title":"The influence of patient positioning uncertainties in proton radiotherapy on proton range and dose distributions","volume":"41","author":"Liebl","year":"2014","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.21037\/jgo.2019.11.07","article-title":"Managing treatment-related uncertainties in proton beam radiotherapy for gastrointestinal cancers","volume":"11","author":"Tryggestad","year":"2020","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0130","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.ijrobp.2009.05.071","article-title":"Radiation dose-volume effects in the stomach and small bowel","volume":"76","author":"Kavanagh","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2009.02.025","article-title":"Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397","volume":"76","author":"Gulliford","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0140","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.radonc.2013.03.029","article-title":"Prediction of rectum and bladder morbidity following radiotherapy of prostate cancer based on motion-inclusive dose distributions","volume":"107","author":"Thor","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0145","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.radonc.2013.10.021","article-title":"Dose\/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions","volume":"109","author":"Thor","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0150","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.ijrobp.2009.02.090","article-title":"Radiation dose-volume effects of the urinary bladder","volume":"76","author":"Viswanathan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2022.04.029","article-title":"Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: results from eight European centres","volume":"172","author":"Hoffmann","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40364-024-00642-5","article-title":"Comparison of proton therapy and photon therapy for early-stage non-small cell lung cancer: a meta-analysis","volume":"12","author":"He","year":"2024","journal-title":"Biomark Res"},{"key":"10.1016\/j.radonc.2026.111404_b0165","doi-asserted-by":"crossref","unstructured":"Stick LB, Lorenzen EL, Yates ES, et al. Selection criteria for early breast cancer patients in the DBCG proton trial - the randomised phase III trial strategy.Clin Transl Radiat Oncol. 2021;27:126-131. Published 2021 Feb 4. doi:10.1016\/j.ctro.2021.01.012.","DOI":"10.1016\/j.ctro.2021.01.012"},{"key":"10.1016\/j.radonc.2026.111404_b0170","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijrobp.2014.04.008","article-title":"Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial","volume":"90","author":"Galland-Girodet","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0175","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2019.04.015","article-title":"Quantification of acute skin toxicities in patients with breast cancer undergoing adjuvant proton versus photon radiation therapy: a single institutional experience","volume":"104","author":"DeCesaris","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.radonc.2014.08.017","article-title":"Quality of life outcomes in proton and photon treated pediatric brain tumor survivors","volume":"113","author":"Yock","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14338\/IJPT-18-00048.1","article-title":"IMPT versus VMAT for pelvic nodal irradiation in prostate cancer: a dosimetric comparison","volume":"5","author":"Whitaker","year":"2019","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2026.111404_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-20-00031.1","article-title":"Consensus statement on proton therapy for prostate cancer","volume":"8","author":"Bryant","year":"2021","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2026.111404_b0195","article-title":"Proton versus photon radiation therapy: a clinical review","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1241711","article-title":"Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study","volume":"13","author":"Ong","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.phro.2022.07.001","article-title":"Dose-volume analysis of planned versus accumulated dose as a predictor for late gastrointestinal toxicity in men receiving radiotherapy for high-risk prostate cancer","volume":"23","author":"Ong","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1084311","article-title":"Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose","volume":"12","author":"Ong","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0215","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/0284186X.2017.1388539","article-title":"Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial","volume":"57","author":"Chuong","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.14338\/IJPT-20-00094.1","article-title":"Proton therapy of prostate and pelvic lymph nodes for high risk prostate cancer: acute toxicity","volume":"8","author":"Choo","year":"2021","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2026.111404_b0225","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2022.11.027","article-title":"Late toxicity of moderately hypofractionated intensity-modulated proton therapy treating the prostate and pelvic lymph nodes for high-risk prostate cancer","volume":"115","author":"Choo","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111404_b0230","article-title":"Proton dose calculation on cone-beam computed tomography using unsupervised 3D deep learning networks","volume":"32","author":"Vestergaard","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phro.2018.06.002","article-title":"A biological modelling based comparison of radiotherapy plan robustness using photons vs protons for focal prostate boosting","volume":"6","author":"Pedersen","year":"2018","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110264","article-title":"Photon vs proton hypofractionation in prostate cancer: a systematic review and meta-analysis","volume":"195","author":"Corrao","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110568","article-title":"Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial","volume":"201","author":"Draulans","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111404_b0250","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1088\/0031-9155\/58\/7\/2103","article-title":"Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver","volume":"58","author":"Carabe","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2026.111404_b0255","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190291","article-title":"Proton RBE dependence on dose in the setting of hypofractionation","volume":"93","author":"Friedrich","year":"2020","journal-title":"Br J Radiol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:16:45Z","timestamp":1785917805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":51,"alternative-id":["S0167814026000423"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111404","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A robustness-inclusive comparison of proton- versus photon-based whole-pelvic radiotherapy for prostate cancer within a randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111404"}}